ArticleMaedica2026
Association of Lipoprotein(a) and ApoB/ApoA1 Ratio with SYNTAX Score in Premature Myocardial Infarction: an Age-Stratified Study from Northeast India.
Article in Maedica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Conventional lipid parameters may not adequately reflect coronary lesion complexity in myocardial infarction (MI), particularly in premature cases. Advanced lipid markers such as lipoprotein(a) [Lp(a)], apolipoprotein B (ApoB) and the ApoB/ApoA1 ratio may better represent atherogenic burden. Aim: To evaluate the association between lipid parameters and SYNTAX score in patients with premature MI. An exploratory age-stratified analysis comparing patients aged <45 years and 45-55 years was additionally performed. Methods: In this hospital-based cross-sectional study, consecutive MI patients aged ≤55 years with angiographically confirmed coronary artery disease (CAD) were enrolled. Blood samples were collected at admission prior to initiation of therapy for assessment of lipid profile, including Lp(a), ApoA1, ApoB and ApoB/ApoA1 ratio. SYNTAX score was categorized as low (≤22) or high (>22). Associations were analysed using Student's t-test, Spearman correlation, multivariate logistic regression and receiver operating characteristic (ROC) curve analysis. Results: Among 100 patients (mean age 46.5 ± 6.2 years; 85% males), 37% had high SYNTAX scores as well as significantly higher Lp(a), ApoB and ApoB/ApoA1 ratio (p<0.01), while conventional lipid parameters were not significantly different. These associations appeared more pronounced among patients aged <45 years and formal interaction analysis provided additional evidence of an age-dependent relationship between Lp(a) and high SYNTAX score [interaction odds ratio (OR) 0.952, 95% confidence interval (CI) 0.917-0.989, p=0.011]. SYNTAX score correlated positively with Lp(a) (ρ=0.275, p=0.006), ApoB (ρ=0.347, p<0.001) and ApoB/ApoA1 ratio (ρ=0.352, p<0.001). In multivariable analysis, hypertension independently predicted high SYNTAX score (adjusted OR 3.46, p=0.012), whereas associations of advanced lipid markers were attenuated after multivariable adjustment. ROC analysis showed modest discriminative ability for Lp(a) (AUC 0.64, 95% CI: 0.52-0.77), with limited performance for ApoB and ApoB/ApoA1 ratio. Conclusion: Advanced lipid markers, particularly Lp(a) and ApoB/ApoA1 ratio, were associated with greater angiographic complexity in premature MI. Exploratory analyses suggested stronger associations among patients aged <45 years, particularly for Lp(a), and formal interaction analysis further supported an age-dependent relationship between Lp(a) and high SYNTAX score. However, their modest discriminative ability and lack of independent association after multivariable adjustment suggest that these markers should be considered adjunctive indicators of atherogenic burden rather than standalone predictors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.